Ei­sai, BioArc­tic to de­vel­op new drug for Alzheimer’s that can cross blood-brain bar­ri­er

Ei­sai and BioArc­tic — the com­pa­nies be­hind the first Alzheimer’s drug proven to slow dis­ease pro­gres­sion — are ink­ing an­oth­er re­search part­ner­ship in the dis­ease, this time …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER